Legend Biotech shares fall 16% after first earnings report under new CEO


Legend Biotech’s shares tumbled 16% Tuesday following the CAR-T company’s third-quarter earnings report, marking a rocky debut for newly installed CEO Ingrid Zhang. | Legend Biotech’s shares tumbled 16% Tuesday following the CAR-T company’s third-quarter earnings report, marking a rocky debut for newly installed CEO Ingrid Zhang.

एक उत्तर छोड़ें

आपका ईमेल पता प्रकाशित नहीं किया जाएगा। आवश्यक फ़ील्ड को * से चिह्नित किया गया है